Silent conditions often develop without noticeable warning signs, making them difficult to detect until they reach advanced stages. Many serious diseases progress quietly while individuals feel healthy.
This is why screening and routine tests are essential tools for early disease detection. By identifying changes in biomarkers, healthcare providers can begin diagnosis and treatment before symptoms appear.
